Biology Reference
In-Depth Information
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., and Möbius H.J., for the
Memantine Study Group. (2003). Memantine in moderate-to-severe Alzheimer's disease.
New England Journal of Medicine, 348,
1333-1341.
Rex, C.S., Lauterborn, J.C., Lin, C.Y., Kramár, E.A., Rogers, G.A., Gall, C.M., and Lynch,
G. (2006). Restoration of long-term potentiation in middle-aged hippocampus after
induction of brain-derived neurotrophic factor.
Journal of Neurophysiology 96,
677-685.
Rex, C.S., Lin, C.Y., Kramár, E.A., Chen, L.Y., Gall, C.M., and Lynch, G. (2007). Brain-
derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes
in adult hippocampus.
Journal of Neuroscience, 27,
3017-3029.
Richardson, J.T. (1990). Cognitive function in diabetes mellitus.
Neuroscience and
Biobehavioral Reviews, 14,
385-388.
Rodriguez-Tebar, A., Dechant, G., and Barde, Y.A. (1990). Binding of brain-derived
neurotrophic factor to the nerve growth factor receptor.
Neuron, 4,
487-492.
Rogaeva, E., Meng, Y., Lee, J.H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C.T.,
Cheng, R., Hasegawa, H., Chen, F., Shibata, N., Kathryn Lunetta, L., Pardossi-Piquard,
R., Bohm, C., Wakutani, Y., Cupples, L.A., Cuenco, K.T., Green, R.C., Pinessi, L.,
Rainero, I., Sorbi, S., Bruni, A., Duara, R., Friedland, R.P., Inzelberg, R., Hampe, W.,
Bujo, H., Song, Y.Q., Andersen, O.M., Willnow, T.E., Graff-Radford, N., Petersen, R.C.,
Dickson, D., Der, S.D., Fraser, P.E., Schmitt-Ulms, G., Younkin, S., Mayeux, R., Farrer,
L.A., and St George-Hyslop, P. (2007). The neuronal sortilin-related receptor SORL1 is
genetically associated with Alzheimer disease.
Nature Genetics, 39,
168-177.
Roses, A.D., Saunders, A.M., Alberts, M.A., Strittmatter, W.J., Schmechel, D., Gorder, E.,
and Pericak-Vance, M.A. (1995). Apolipoprotein E E4 allele and risk of dementia.
Journal of the American Medical Association, 273,
374-375.
Ross, F.M., Allan, S.M., Rothwell, N.J., and Verkhratsky, A. (2003). A dual role for
interleukin-1 in LTP in mouse hippocampal slices.
Journal of Neuroimmunology, 144,
61-67.
Rowan, M.J., Klyubin, I., Wang, Q., Hu, N.W., and Anwyl, R. (2007). Synaptic memory
mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction.
Biochemical
Society Transactions, 35,
1219-1223.
Rudelli, R., Brown, W., Wisniewski, K., Jenkins, E., Laure-Kamionowska, M., Connell, F.,
and Wisniewski, H. (1985). Adult fragile X syndrome. Clinico-neuropathologic findings.
Acta Neuropathologica, 67,
289-295.
Ruggero, D. and Sonenberg, N. (2005). The Akt of translational control.
Oncogene, 24,
7426-
7434.
Saffell, J.L., Williams, E.J. Mason, I.J., Walsh, F.S. and Doherty, P. (1997). Expression of a
dominant negative FGF receptor inhibits axonal growth and FGF receptor
phosphorylation stimulated by CAMs.
Neuron, 18,
231-242.
Sakamoto, H., Mezaki, Y., Shikimi, H., Ukena, K. and Tsutsui, K. (2003). Dendritic growth
and spine formation in response to estrogen in the developing Purkinje cell.
Endocrinology, 144,
4466-4477.
Salehi, A., Delcroix, J.-D. and Mobley, W.C. (2003). Traffic at the intersection of
neurotrophic factor signaling and neurodegeneration.
Trends in Neuroscience, 26,
73-80.
Sanchez-Heras, E., Howell, F.V., Williams, G. and Doherty, P. (2006). The fibroblast growth
factor receptor acid box is essential for interactions with N-cadherin and all of the major
